LIF, a novel STAT5-regulated gene, is aberrantly expressed in myeloproliferative neoplasms

Genes and Cancer

Volumn 2, Issue 5, 2011, Pages 593-596

  Salas, Elisa M ^a   García Barchino, María J ^a   Labiano, Sara ^a   Shugay, Mikhail ^a   Pérez Encinas, Manuel ^b   Quinteiro, Celsa ^c   García Delgado, Marina ^a   Vizmanos, José L ^a   Novo, Francisco J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c Fundacion Publica Galega de Medicina Xenomica   (Spain)

Author keywords

LIF; myeloproliferative neoplasms; STAT5

Indexed keywords

MESSENGER RNA;

ARTICLE; BONE MARROW CANCER; CARCINOGENESIS; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; GENE; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; JANUS KINASE 2 GENE; LEUKEMIA INHIBITORY FACTOR GENE; MALE; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5 GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR DIFFERENTIATION;

EID: 80052998813     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601911420139     Document Type: Article

References (8)

1. Kota J,Caceres N,Constantinescu SN.Aberrant signal transduction pathways in myeloproliferative neoplasms.Leukemia. 2008;22:1828-40.
2. Goldman JM,Green AR,Holyoake T, et al.Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues.Leukemia. 2009;23:1708-15.
3. Trouillas M,Saucourt C,Guillotin B, et al.The LIF cytokine: towards adulthood.Eur Cytokine Netw. 2009;20:51-62.
4. Niwa H,Ogawa K,Shimosato D,Adachi K.A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells.Nature. 2009;460:118-22.
5. Felli N,Cianetti L,Pelosi E, et al.Hematopoietic differentiation: a coordinated dynamical process towards attractor stable states.BMC Syst Biol. 2010;4:85.
6. Fatrai S,Wierenga AT,Daenen SM,Vellenga E,Schuringa JJ.Identification of HIF2{alpha} as an important STAT5 target gene in human hematopoietic stem cells.Blood. 2011;117:3320-30.
7. Iwamoto T,Senga T,Adachi K,Hamaguchi M.Stat3-dependent induction of interleukin-3 receptor expression in leukemia inhibitory factor-stimulated M1 mouse leukemia cells.Cytokine. 2004;25:136-9.
8. Chen E,Beer PA,Godfrey AL, et al.Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling.Cancer Cell. 2010;18:524-35.